Oxidative Remodeling in Pressure Overload Induced Chronic Heart Failure
Abstract
Despite extensive strides in understanding pressure overload induced heart failure, there is very little known about oxidative stress induced matrix metalloproteinase (MMP) activation, collagen degradation and remodeling in pressure overload heart failure. We hypothesize that pressure overload leads to redox imbalance causing increased expression/activity of MMP-2/9 producing collagen degradation and heart failure. To test this hypothesis, we created pressure overload heart failure by abdominal aortic stenosis (AS) in wild-type C57BL/6J and collagen mutant (Col1a1 with 129 s background) mice. At 4 weeks, post surgery, functional parameters were measured. Left ventricle (LV) tissue sections were analyzed by histology, Western Blot and PCR. The results suggest an increase in iNOS with a decrease in eNOS, an increase in nitrated protein modification and depletion of antioxidants thioredoxin and SOD in pressure overload. MMP-2/9 expression/activity and collagen degradation were increased in the AS animals. To determine whether a mutation in the collagen gene at the site of MMP cleavage mitigates cardiac hypertrophy, we used Col1a1 mice. In these mice, the AS induced LV hypertrophy (LVH) was ameliorated. In conclusion, our results suggest that AS leads to increased oxidative stress, expression/activity of MMP-2/9 and a decrease in antioxidant expression producing collagen degradation and heart failure.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a pressure-overload model of heart failure in mice, increased collagen degradation as a result of elevated expression and activity of MMP-2/9 correlated with development of heart failure.
“Furthermore, in a pressure-overload model of heart failure in mice, an increased collagen degradation as a result of elevated expression and activity of MMP-2/9 correlated with development of heart failure (135).”
From Cardiac remodeling in obesity (2008) · cites this paper as [135]
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,905 · see citing works
Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., & Galis, Z. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119076 · Cited by 1,137 · see citing works
Cardiac interstitium in health and disease: The fibrillar collagen network
Weber, K. T. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90360-4 · Cited by 1,060 · see citing works
Kojda, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00169-8 · Cited by 769 · see citing works
Springman, E. B., Angleton, E. L., Birkedal‐Hansen, H., & Wart, H. E. V. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.364 · Cited by 713 · see citing works
Siwik, D. A., Pagano, P. J., & Colucci, W. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c53 · Cited by 674 · see citing works
Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial Hypertrophy
Akhter, S. A., Luttrell, L. M., Rockman, H. A., Iaccarino, G., Lefkowitz, R. J., & Koch, W. J. (1998) · Science · doi:10.1126/science.280.5363.574 · Cited by 452 · see citing works
Takimoto, E., Champion, H. C., Li, M., Ren, S. V., Rodríguez, E. R., Tavazzi, B., Lazzarino, G., Paolocci, N., Gabrielson, K. L., Wang, Y., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci21968 · Cited by 446 · see citing works
MacKenna, D. A. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00030-4 · Cited by 387 · see citing works
Peterson, J. T., Hallak, H., Johnson, L., Li, H., O’Brien, P. M., Sliskovic, D. R., Bocan, T. M. A., Coker, M. L., Etoh, T., & Spinale, F. G. (2001) · Circulation · doi:10.1161/01.cir.103.18.2303 · Cited by 300 · see citing works
Liu, X., Wu, H., Byrne, M. H., Jeffrey, J. J., Krane, S. M., & Jaenisch, R. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.130.1.227 · Cited by 282 · see citing works
Increased Superoxide Production in Coronary Arteries in Hyperhomocysteinemia
Ungvari, Z. I., Csiszár, A., Edwards, J. G., Kaminski, P. M., Wolin, M. S., Kaley, G., & Koller, Á. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000061735.85377.40 · Cited by 267 · see citing works
Oxidative stress and heart failure
MacCarthy, P. A., & Shah, A. M. (2003) · Coronary Artery Disease · doi:10.1097/00019501-200304000-00003 · Cited by 166 · see citing works
Kameda, K. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.022 · Cited by 161 · see citing works
Myocardial matrix metalloproteinase(s): localization and activation
Tyagi, S. C., Ratajska, A., & Weber, K. T. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf01772207 · Cited by 141 · see citing works
Self-citationCannella, G., Paoletti, E., Delfino, R., Peloso, G., Rolla, D., & Molinari, S. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90490-x · Cited by 132 · see citing works
Matrix Metalloproteinase Disruption of the Extracellular Matrix and Cardiac Dysfunction
D'Armiento, J. M. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00160-8 · Cited by 123 · see citing works
Mujumdar, V. S., & Tyagi, S. C. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00011 · Cited by 118 · see citing works
Self-citationDifferential gene expression of extracellular matrix components in dilated cardiomyopathy
Tyagi, S. C., Kumar, S., Voelker, D. J., Reddy, H. K., Janicki, J. S., & Curtis, J. J. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19961101)63:2 · Cited by 100 · see citing works
Self-citationSerum Thioredoxin (TRX) Levels in Patients With Heart Failure
Kishimoto, C., Shioji, K., Nakamura, H., Nakayama, Y., Yodoi, J., & Sasayama, S. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.491 · Cited by 94 · see citing works
Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium
Tyagi, S. C., Kumar, S. G., Banks, J., & Fortson, W. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(95)91443-9 · Cited by 76 · see citing works
Self-citationInduction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure
Hunt, M. J., Aru, G. M., Hayden, M. R., Moore, C. K., Hoit, B. D., & Tyagi, S. C. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00001.2002 · Cited by 64 · see citing works
Self-citationHomocyst(e)ine impairs endocardial endothelial function
Tyagi, S. C., Smiley, L. M., & Mujumdar, V. S. (1999) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-77-12-950 · Cited by 45 · see citing works
Self-citationProtease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure
Moshal, K. S., Tyagi, N., Henderson, B. C., Ovechkin, A. V., & Tyagi, S. C. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01146.2004 · Cited by 40 · see citing works
Self-citationMaru, Y., Yamaguchi, S., Takahashi, T., Ueno, H., & Shibuya, M. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199808)176:2 · Cited by 37 · see citing works
Self-citationHomocyst(e)ine impairs endocardial endothelial function
Tyagi, S. C., Smiley, L. M., & Mujumdar, V. S. (1999) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-102 · Cited by 31 · see citing works
Self-citation[Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
Ma, Q., Xie, Y., & Zhang, S. (2002) · PubMed · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736 · see citing works
Sbardella, D., Fasciglione, G. F., Gioia, M., Ciaccio, C., Tundo, G. R., Marini, S., & Coletta, M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.015 · Cited by 248 · see citing works
Role of estrogen in diastolic dysfunction
Zhao, Z., Wang, H., Jessup, J. A., Lindsey, S. H., Chappell, M. C., & Groban, L. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00859.2013 · Cited by 205 · see citing works
Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?
Galat, A., Guellich, A., Bodez, D., Slama, M., Dijos, M., Messika–Zeitoun, D., Milleron, O., Attias, D., Dubois‐Randé, J., Mohty, D., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw033 · Cited by 151 · see citing works
NADPH Oxidases in Lung Health and Disease
Bernard, K. F., Hecker, L., Luckhardt, T., Cheng, G., & Thannickal, V. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5608 · Cited by 108 · see citing works
ROS regulation of microdomain Ca2+ signalling at the dyads
Zhang, H., Gomez, A. M., Wang, X., Yan, Y., Zheng, M., & Cheng, H. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt050 · Cited by 72 · see citing works
Fisetin inhibits cardiac hypertrophy by suppressing oxidative stress
Dong, B., Liu, C., Xue, R., Wang, Y., Sun, Y., Liang, Z., Fan, W., Jiang, J., Zhao, J., Su, Q., et al. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.08.010 · Cited by 62 · see citing works
Enhanced oxidative stress in hypertrophic cardiomyopathy
Dimitrow, P. P., Undas, A., Wołkow, P. P., Tracz, W., & Dubiel, J. S. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70091-x · Cited by 47 · see citing works
Jiao, J., Wei, Y., Chen, J., Chen, X., & Zhang, Y. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2016.12.039 · Cited by 44 · see citing works
Henderson, B. C., Sen, U., Reynolds, C. L., Moshal, K. S., Ovechkin, A. V., Tyagi, N., Kartha, G., Rodriguez, W. E., & Tyagi, S. C. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.385 · Cited by 42 · see citing works
Self-citationActivation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs
Sharma, A. K., Dhingra, S., Khaper, N., & Singal, P. K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00553.2007 · Cited by 40 · see citing works
Tănase, D. M., Valasciuc, E., Gosav, E. M., Floria, M., Costea, C. F., Dima, N., Tudorancea, I., Maranducă, M. A., & Șerban, I. L. (2022) · Cells · doi:10.3390/cells11172663 · Cited by 37 · see citing works
Copper chelation in patients with hypertrophic cardiomyopathy
Reid, A. B., Miller, C., Farrant, J. P., Polturi, R., Clark, D., Ray, S. G., Cooper, G. J. S., & Schmitt, M. (2022) · Open Heart · doi:10.1136/openhrt-2021-001803 · Cited by 28 · see citing works
Sun, Y., Carretero, O. A., Xu, J., Rhaleb, N., Yang, J. J., Pagano, P. J., & Yang, X.-P. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.121822 · Cited by 26 · see citing works
Valvular heart disease and cardiomyopathy: reappraisal of their interplay
Marsan, N. A., Graziani, F., Meucci, M. C., Wu, H. W., Lillo, R., Bax, J. J., Burzotta, F., Massetti, M., Jukema, J. W., & Crea, F. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00911-0 · Cited by 22 · see citing works
Foltz, W. U., Wagner, M., Rudakova, E., & Volk, T. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0290-4 · Cited by 22 · see citing works
Suppression of TGP on myocardial remodeling by regulating the NF-κB pathway
Naveed, M., Han, L., Hasnat, M., Baig, M. M. F. A., Wang, W., Mikrani, R., Zhiwei, L., Sembatya, K. R., Xie, D., & Zhou, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.168 · Cited by 21 · see citing works
Aortic Valve Stenosis and Cardiac Amyloidosis: A Misleading Association
Bonelli, A., París, S. C., Nardi, M., Henein, M. Y., Agricola, E., Troise, G., & Faggiano, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184234 · Cited by 18 · see citing works
Ott, C., Jung, T., Brix, S., John, C., Betz, I. R., Foryst‐Ludwig, A., Deubel, S., Kuebler, W. M., Grune, T., Kintscher, U., et al. (2021) · Cells · doi:10.3390/cells10040805 · Cited by 18 · see citing works
Mosele, F., Tavares, Â. M. V., Colombo, R., Caron-Lienert, R. S., Araújo, A. S. D. R., Ribeiro, M. F. M., & Belló‐Klein, A. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182550fd6 · Cited by 18 · see citing works
Ferreira, V. V., Rosa, S. A., Pereira‐da‐Silva, T., Rodrigues, I., Gonçalves, A. V., Mendonca, T., Castelo, A., Branco, L. M., Galrinho, A., Fiarresga, A. J., et al. (2021) · PubMed Central · Cited by 17 · see citing works
Sant’Ana, P. G., Batah, S. S., Leão, P. D. S., Teodoro, W. R., de Souza, S. L. B., Mota, G. A. F., Vileigas, D. F., da Silva, V. L., de Campos, D. H. S., Okoshi, K., et al. (2018) · Pathophysiology · doi:10.1016/j.pathophys.2018.07.001 · Cited by 12 · see citing works
Rodriguez, W. E., Tyagi, N., Deng, A. Y., Adeagbo, A., Joshua, I. G., & Tyagi, S. C. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802535978 · Cited by 11 · see citing works
Self-citationAhmed, A. M. A. (2016) · Folia Morphologica · doi:10.5603/fm.a2016.0043 · Cited by 10 · see citing works
Microplastics and Nanoplastics in Cardiovascular Disease: An Emerging Cardiovascular Risk Factor
Polimeni, A., Castiello, D. S., Quarta, R., Gori, T., Martino, G., Romano, L. R., Meringolo, F., Lopes, G. T. A., Yasuda, M., Indolfi, C., et al. (2026) · Cardiovascular Toxicology · doi:10.1007/s12012-026-10112-z · Cited by 8 · see citing works
Kuster, G. M., Nietlispach, F., Kiowski, W., Schindler, R., Bernheim, A., Schüetz, P., Müeller, B., Morgenthaler, N. G., Rüter, F., Riesen, W., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.36 · Cited by 5 · see citing works
Antonopoulos, A. S., Tsampras, T., Kanatas, P. J., Ktenopoulos, N., Koutelou, M., Panagiotopoulos, I. A., Kyriakopoulos, D., Koliastasis, L., Ioannidis, M., Eftychiou, C., et al. (2026) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2026.03.002 · Cited by 1 · see citing works
Papel del estrés oxidativo y nitrosativo en la hipertrofia cardiaca y remodelación ventricular
Giraldo, A. (2019) · Acta Médica Colombiana · doi:10.36104/amc.2010.1570
Myoblast transplantation and adenoviral VEGF-C transfer in porcine model of coronary artery disease
Pätilä, T. (2009) · Työväentutkimus Vuosikirja
Cuadrado, I., Egido, J., Zamorano, J. L., & Zaragoza, C. (2016) · Imaging in medical diagnosis and therapy · doi:10.1201/b19052-6
Pharmacological cardioprotection of the human myocardium in diseased states
Rees, P. S. C. (2011) · UCL Discovery (University College London)
- Authors
- Henderson, B. C., Tyagi, N., Ovechkin, A., Kartha, G. K., Moshal, K. S., & Tyagi, S. C.
- Affiliations
- University of Louisville (US)
- Corresponding author
- Henderson, Brooke C.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 9
- Issue
- 5
- Pages
- 450-457
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2064525822
- Cited by
- 32
- References
- 27
- Citations by year
- 2026: 2 · 2023: 1 · 2022: 2 · 2021: 3 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 3 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL074185, HL 74185)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- pressure overload, chronic heart failure, oxidative stress, MMP-2, MMP-9, collagen degradation, cardiac remodeling, abdominal aortic stenosis, left ventricular hypertrophy, nitric oxide synthase, nitrated proteins, thioredoxin, superoxide dismutase, redox imbalance
- MeSH terms
- Analysis of Variance, Animals, Aortic Valve Stenosis, Blood Pressure, Chronic Disease, Collagen, Disease Models, Animal, Echocardiography, Elastin, Electrocardiography, Enzyme Activation, Heart Failure, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Research Design, Stroke Volume, Blotting, Western, Hypertrophy, Left Ventricular, Oxidative Stress, Ventricular Dysfunction, Left, Reverse Transcriptase Polymerase Chain Reaction, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Mice, Nitric Oxide Synthase Type II, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review